Sarepta therapeutics announces fourth quarter and full-year 2021 financial results and recent corporate developments

Cambridge, mass., march 01, 2022 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2021.
SRPT Ratings Summary
SRPT Quant Ranking